The report was what I has been expected from the threads on this forum , and I know that we have to be patient to see what the next quarterly figures bring . However I hope that there will other positive announcements during this period that will excit the market .
Does any one know why the report didn't mentioned the Cardiocel MiddleEast exposure through the third party health care company relationship,that was announced earlier this year?
Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.55 |
Change
-1.500(8.80%) |
Mkt cap ! $299.4M | |||
| Open | High | Low | Value | Volume |
| $16.50 | $16.50 | $15.52 | $533.1K | 33.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2504 | $15.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.70 | 65 | 2 |
View Market Depth
| Last trade - 14.09pm 24/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |